Increased Circulating Levels of SDF-1 (CXCL12) in Type 2 Diabetic Patients Are Correlated to Disease State but Are Unrelated to Polymorphism of the SDF-1β Gene in the Iranian Population
- 4 October 2011
- journal article
- Published by Springer Nature in Inflammation
- Vol. 35 (3) , 900-904
Abstract
Several environmental and genetic factors are believed to influence the onset of diabetes and its complications. It has also been established that cytokines play a key role in the pathogenesis of type 2 diabetes. Previous studies have revealed that the polymorphism at the stromal-derived factor 1β (SDF-1β) 3′A regulates the expression of SDF-1 (CXCL12). This study was aimed to explore this polymorphism in parallel with SDF-1 serum levels in type 2 diabetic patients. In this assessment, peripheral blood samples were collected from 200 type 2 diabetic patients and 200 healthy controls. DNA was extracted, and a PCR-RFLP screening was applied to examine the SDF-1β 3′A polymorphism. We also applied the ELISA technique to measure serum levels of SDF-1. Our results showed that there were no significant correlations between SDF-1β 3′Α polymorphism in type 2 diabetic patients when compared to controls. However, our results showed that the serum levels of SDF-1 were significantly increased in the patients when compared to controls. Based on the results of this study, we concluded that SDF-1β 3′Α polymorphism does not play a role in the pathogenesis of type 2 diabetes but that elevated serum levels of SDF-1 may be important for the etiology of type 2 diabetes but are unrelated to the SDF-1β 3′Α polymorphism.Keywords
This publication has 19 references indexed in Scilit:
- Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor populationGut, 2010
- Assessment of CXCL12 (SDF-1α) Polymorphisms and Its Serum Level in Posttransfusion Occult HBV-infected Patients in Southeastern IranArchives of Medical Research, 2010
- Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?Diabetes Research and Clinical Practice, 2010
- Angiotensin II and the development of insulin resistance: Implications for diabetesMolecular and Cellular Endocrinology, 2009
- Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endotheliumMolecular and Cellular Endocrinology, 2009
- Nutrition interventions for the prevention of type 2 diabetesProceedings of the Nutrition Society, 2008
- Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathyJournal of Diabetes and its Complications, 2005
- Intracellular IFN- γ Production and IL-12 Serum Levels in Latent Autoimmune Diabetes of Adults (LADA) and in Type 2 DiabetesJournal of Interferon & Cytokine Research, 2004
- The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein–Barr virus-transformed lymphoblastoid cellsGenes & Immunity, 2003
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000